Sekvensbehandling af postmenopausal osteoporose

Pia Eiken; Jane Dahl Andersen; Anne Pernille Hermann; Jens Erik Beck Jensen; Bente L. Langdahl

doi:10.61409/V03250171

Sekvensbehandling af postmenopausal osteoporose

Translated title of the contribution: Sequence treatment of postmenopausal osteoporosis

Pia Eiken^*, Jane Dahl Andersen, Anne Pernille Hermann, Jens Erik Beck Jensen, Bente L. Langdahl

^*Corresponding author for this work

Abstract

Initial therapy for low-risk patients typically involves potent antiresorptive agents such as bisphosphonates or denosumab to reduce bone resorption and fracture risk. For high-risk patients, bone anabolic agents like teriparatide or romosozumab may be preferred to stimulate bone formation, rapidly increase bone mass and enhance fracture prevention. Effective transitions between therapies are essential to sustain skeletal benefits. This review explores evidence-based strategies for sequential osteoporosis treatment.

Translated title of the contribution	Sequence treatment of postmenopausal osteoporosis
Original language	Danish
Article number	V03250171
Journal	Ugeskrift for Laeger
Volume	187
Issue number	43
Pages (from-to)	1-9
Number of pages	9
ISSN	0041-5782
DOIs	https://doi.org/10.61409/V03250171
Publication status	Published - 20 Oct 2025

Access to Document

10.61409/V03250171Licence: CC BY-NC-ND

Cite this

@article{d4dcde2dfbd64292b0a01fb62bbdf2cd,

title = "Sekvensbehandling af postmenopausal osteoporose",

abstract = "Initial therapy for low-risk patients typically involves potent antiresorptive agents such as bisphosphonates or denosumab to reduce bone resorption and fracture risk. For high-risk patients, bone anabolic agents like teriparatide or romosozumab may be preferred to stimulate bone formation, rapidly increase bone mass and enhance fracture prevention. Effective transitions between therapies are essential to sustain skeletal benefits. This review explores evidence-based strategies for sequential osteoporosis treatment.",

author = "Pia Eiken and Andersen, \{Jane Dahl\} and Hermann, \{Anne Pernille\} and Jensen, \{Jens Erik Beck\} and Langdahl, \{Bente L.\}",

note = "Publisher Copyright: Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2025",

month = oct,

day = "20",

doi = "10.61409/V03250171",

language = "Dansk",

volume = "187",

pages = "1--9",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "43",

}

TY - JOUR

T1 - Sekvensbehandling af postmenopausal osteoporose

AU - Eiken, Pia

AU - Andersen, Jane Dahl

AU - Hermann, Anne Pernille

AU - Jensen, Jens Erik Beck

AU - Langdahl, Bente L.

N1 - Publisher Copyright: Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2025/10/20

Y1 - 2025/10/20

N2 - Initial therapy for low-risk patients typically involves potent antiresorptive agents such as bisphosphonates or denosumab to reduce bone resorption and fracture risk. For high-risk patients, bone anabolic agents like teriparatide or romosozumab may be preferred to stimulate bone formation, rapidly increase bone mass and enhance fracture prevention. Effective transitions between therapies are essential to sustain skeletal benefits. This review explores evidence-based strategies for sequential osteoporosis treatment.

AB - Initial therapy for low-risk patients typically involves potent antiresorptive agents such as bisphosphonates or denosumab to reduce bone resorption and fracture risk. For high-risk patients, bone anabolic agents like teriparatide or romosozumab may be preferred to stimulate bone formation, rapidly increase bone mass and enhance fracture prevention. Effective transitions between therapies are essential to sustain skeletal benefits. This review explores evidence-based strategies for sequential osteoporosis treatment.

UR - https://www.scopus.com/pages/publications/105022224163

U2 - 10.61409/V03250171

DO - 10.61409/V03250171

M3 - Review

C2 - 41251243

AN - SCOPUS:105022224163

SN - 0041-5782

VL - 187

SP - 1

EP - 9

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 43

M1 - V03250171

ER -

Sekvensbehandling af postmenopausal osteoporose

Abstract

Access to Document

Other files and links

Fingerprint

Cite this